Skip to main content
PMC home page
Gut logoLink to Gut
. 1999 Dec;45(Suppl 6):VI1–VI22.

Indications for referral and assessment in adultliver transplantation: a clinical guideline

J Devlin, J O'Grady
PMCID: PMC1766725  PMID: 10561164

Full Text

The Full Text of this article is available as a PDF (225.2 KB).

Figure 1  .

Figure 1  

Open in a new tab

Reported mortality from alcohol related liver disease in the United Kingdom.

Figure 2  .

Figure 2  

Open in a new tab

Rapid decline in de novo hepatitis C (HCV) infection (United States).

Figure 3  .

Figure 3  

Open in a new tab

De novo acute hepatitis B infection in the United Kingdom.

Figure 4  .

Figure 4  

Open in a new tab

Importance of paracetamol overdoses in drug parasuicides in the United Kingdom.

Figure 5  .

Figure 5  

Open in a new tab

Prevalence data indicate infection with hepatitis A in older age groups.

Figure 6  .

Figure 6  

Open in a new tab

Supraregionally funded liver transplant centres in the United Kingdom.

Figure 7  .

Figure 7  

Open in a new tab

Possible reasons for low rate of transplantation in alcoholic liver disease.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Elmagd K. M., Malinchoc M., Dickson E. R., Fung J. J., Murtaugh P. A., Langworthy A. L., Demetris A. J., Krom R. A., Van Thiel D. H., Starzl T. E. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet. 1993 Oct;177(4):335–344. [PMC free article] [PubMed] [Google Scholar]
  2. Ahn S. S., Yellin A., Sheng F. C., Colonna J. O., Goldstein L. I., Busuttil R. W. Selective surgical therapy of the Budd-Chiari syndrome provides superior survivor rates than conservative medical management. J Vasc Surg. 1987 Jan;5(1):28–37. [PubMed] [Google Scholar]
  3. Alessiani M., Tzakis A., Todo S., Demetris A. J., Fung J. J., Starzl T. E. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 1995 Jan;180(1):1–9. [PMC free article] [PubMed] [Google Scholar]
  4. Alter M. J., Margolis H. S., Krawczynski K., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Gerber M. A., Sampliner R. E. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992 Dec 31;327(27):1899–1905. doi: 10.1056/NEJM199212313272702. [DOI] [PubMed] [Google Scholar]
  5. Arria A. M., Tarter R. E., Starzl T. E., Van Thiel D. H. Improvement in cognitive functioning of alcoholics following orthotopic liver transplantation. Alcohol Clin Exp Res. 1991 Dec;15(6):956–962. doi: 10.1111/j.1530-0277.1991.tb05195.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baliga P., Merion R. M., Turcotte J. G., Ham J. M., Henley K. S., Lucey M. R., Schork A., Shyr Y., Campbell D. A., Jr Preoperative risk factor assessment in liver transplantation. Surgery. 1992 Oct;112(4):704–711. [PubMed] [Google Scholar]
  7. Belle S. H., Detre K. M. Report from the Pitt-UNOS Liver Transplant Registry. Transplant Proc. 1993 Feb;25(1 Pt 2):1137–1142. [PubMed] [Google Scholar]
  8. Berman M. A., Burnham J. A., Sheahan D. G. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol. 1988 Jul;19(7):784–794. doi: 10.1016/s0046-8177(88)80261-2. [DOI] [PubMed] [Google Scholar]
  9. Bernuau J., Goudeau A., Poynard T., Dubois F., Lesage G., Yvonnet B., Degott C., Bezeaud A., Rueff B., Benhamou J. P. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986 Jul-Aug;6(4):648–651. doi: 10.1002/hep.1840060417. [DOI] [PubMed] [Google Scholar]
  10. Bismuth H., Chiche L., Adam R., Castaing D., Diamond T., Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993 Aug;218(2):145–151. doi: 10.1097/00000658-199308000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bismuth H., Morino M., Sherlock D., Castaing D., Miglietta C., Cauquil P., Roche A. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 1992 Apr;163(4):387–394. doi: 10.1016/0002-9610(92)90039-t. [DOI] [PubMed] [Google Scholar]
  12. Bonino F. The importance of hepatitis B viral DNA in serum and liver. J Hepatol. 1986;3(1):136–141. doi: 10.1016/s0168-8278(86)80158-1. [DOI] [PubMed] [Google Scholar]
  13. Bonsel G. J., Klompmaker I. J., van't Veer F., Habbema J. D., Slooff M. J. Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis. Lancet. 1990 Mar 3;335(8688):493–497. doi: 10.1016/0140-6736(90)90734-m. [DOI] [PubMed] [Google Scholar]
  14. Bouchier I. A., Hislop W. S., Prescott R. J. A prospective study of alcoholic liver disease and mortality. J Hepatol. 1992 Nov;16(3):290–297. doi: 10.1016/s0168-8278(05)80659-2. [DOI] [PubMed] [Google Scholar]
  15. Brentnall T. A., Haggitt R. C., Rabinovitch P. S., Kimmey M. B., Bronner M. P., Levine D. S., Kowdley K. V., Stevens A. C., Crispin D. A., Emond M. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996 Feb;110(2):331–338. doi: 10.1053/gast.1996.v110.pm8566577. [DOI] [PubMed] [Google Scholar]
  16. Broomé U., Olsson R., Löf L., Bodemar G., Hultcrantz R., Danielsson A., Prytz H., Sandberg-Gertzén H., Wallerstedt S., Lindberg G. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996 Apr;38(4):610–615. doi: 10.1136/gut.38.4.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bruix J., Castells A., Bosch J., Feu F., Fuster J., Garcia-Pagan J. C., Visa J., Bru C., Rodés J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996 Oct;111(4):1018–1022. doi: 10.1016/s0016-5085(96)70070-7. [DOI] [PubMed] [Google Scholar]
  18. Buskirk S. J., Gunderson L. L., Schild S. E., Bender C. E., Williams H. J., Jr, McIlrath D. C., Robinow J. S., Tremaine W. J., Martin J. K., Jr Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg. 1992 Feb;215(2):125–131. doi: 10.1097/00000658-199202000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Calne R. Y., Williams R. Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J. 1968 Nov 30;4(5630):535–540. doi: 10.1136/bmj.4.5630.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Campbell D. A., Jr, Rolles K., Jamieson N., O'Grady J., Wight D., Williams R., Calne R. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet. 1988 Jun;166(6):511–518. [PubMed] [Google Scholar]
  21. Carr B. I., Iwatsuki S., Starzl T. E., Selby R., Madariaga J. Regional cancer chemotherapy for advanced stage hepatocellular carcinoma. J Surg Oncol Suppl. 1993;3:100–103. doi: 10.1002/jso.2930530528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Castells A., Bruix J., Brú C., Ayuso C., Roca M., Boix L., Vilana R., Rodés J. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology. 1995 Sep;109(3):917–922. doi: 10.1016/0016-5085(95)90402-6. [DOI] [PubMed] [Google Scholar]
  23. Christensen E., Bremmelgaard A., Bahnsen M., Andreasen P. B., Tygstrup N. Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol. 1984 Jan;19(1):90–96. [PubMed] [Google Scholar]
  24. Clements D., Hubscher S., West R., Elias E., McMaster P. Epithelioid haemangioendothelioma. A case report. J Hepatol. 1986;2(3):441–449. doi: 10.1016/s0168-8278(86)80055-1. [DOI] [PubMed] [Google Scholar]
  25. Collis I., Burroughs A., Rolles K., Lloyd G. Psychiatric and social outcome of liver transplantation. Br J Psychiatry. 1995 Apr;166(4):521–524. doi: 10.1192/bjp.166.4.521. [DOI] [PubMed] [Google Scholar]
  26. Commander M., Neuberger J., Dean C. Psychiatric and social consequences of liver transplantation. Transplantation. 1992 May;53(5):1038–1040. doi: 10.1097/00007890-199205000-00013. [DOI] [PubMed] [Google Scholar]
  27. Cottone M., Virdone R., Fusco G., Orlando A., Turri M., Caltagirone M., Maringhini A., Sciarrino E., Demma I., Nicoli N. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment. Gastroenterology. 1989 Jun;96(6):1566–1571. doi: 10.1016/0016-5085(89)90528-3. [DOI] [PubMed] [Google Scholar]
  28. Couetil J. P., Soubrane O., Houssin D. P., Dousset B. E., Chevalier P. G., Guinvarch A., Loulmet D., Achkar A., Carpentier A. F. Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children. Transpl Int. 1997;10(1):33–39. doi: 10.1007/BF02044339. [DOI] [PubMed] [Google Scholar]
  29. Craig J. R., Peters R. L., Edmondson H. A., Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980 Jul 15;46(2):372–379. doi: 10.1002/1097-0142(19800715)46:2<372::aid-cncr2820460227>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  30. Czaja A. J., Davis G. L., Ludwig J., Baggenstoss A. H., Taswell H. F. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology. 1983 Sep;85(3):713–717. [PubMed] [Google Scholar]
  31. Czaja A. J., Hay J. E., Rakela J. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc. 1990 Jan;65(1):23–30. doi: 10.1016/s0025-6196(12)62106-5. [DOI] [PubMed] [Google Scholar]
  32. D'Amico G., Morabito A., Pagliaro L., Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986 May;31(5):468–475. doi: 10.1007/BF01320309. [DOI] [PubMed] [Google Scholar]
  33. Davies M. H., Langman M. J., Elias E., Neuberger J. M. Liver disease in a district hospital remote from a transplant centre: a study of admissions and deaths. Gut. 1992 Oct;33(10):1397–1399. doi: 10.1136/gut.33.10.1397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Dennis C. M., McNeil K. D., Dunning J., Stewart S., Friend P. J., Alexander G., Higenbottam T. W., Calne R. Y., Wallwork J. Heart-lung-liver transplantation. J Heart Lung Transplant. 1996 May;15(5):536–538. [PubMed] [Google Scholar]
  35. Devlin J., Smith H. M., O'Grady J. G., Portmann B., Tan K. C., Williams R. Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients. J Hepatol. 1994 Aug;21(2):204–210. doi: 10.1016/s0168-8278(05)80396-4. [DOI] [PubMed] [Google Scholar]
  36. Devlin J., Wendon J., Heaton N., Tan K. C., Williams R. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatology. 1995 Apr;21(4):1018–1024. [PubMed] [Google Scholar]
  37. Dickson E. R., Grambsch P. M., Fleming T. R., Fisher L. D., Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology. 1989 Jul;10(1):1–7. doi: 10.1002/hep.1840100102. [DOI] [PubMed] [Google Scholar]
  38. Dickson E. R., Murtaugh P. A., Wiesner R. H., Grambsch P. M., Fleming T. R., Ludwig J., LaRusso N. F., Malinchoc M., Chapman R. W., Kaplan M. M. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology. 1992 Dec;103(6):1893–1901. doi: 10.1016/0016-5085(92)91449-e. [DOI] [PubMed] [Google Scholar]
  39. Dousset B., Houssin D., Soubrane O., Boillot O., Baudin F., Chapuis Y. Metastatic endocrine tumors: is there a place for liver transplantation? Liver Transpl Surg. 1995 Mar;1(2):111–117. doi: 10.1002/lt.500010208. [DOI] [PubMed] [Google Scholar]
  40. Dreiling D. A., Koller M. The natural history of alcoholic pancreatitis: update 1985. Mt Sinai J Med. 1985 May;52(5):340–342. [PubMed] [Google Scholar]
  41. Dubrey S. W., Davidoff R., Skinner M., Bergethon P., Lewis D., Falk R. H. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation. 1997 Jul 15;64(1):74–80. doi: 10.1097/00007890-199707150-00014. [DOI] [PubMed] [Google Scholar]
  42. Eccles M., Clapp Z., Grimshaw J., Adams P. C., Higgins B., Purves I., Russell I. North of England evidence based guidelines development project: methods of guideline development. BMJ. 1996 Mar 23;312(7033):760–762. doi: 10.1136/bmj.312.7033.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ellis A. J., Wendon J. A., Portmann B., Williams R. Acute liver damage and ecstasy ingestion. Gut. 1996 Mar;38(3):454–458. doi: 10.1136/gut.38.3.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Esteban J. I., Esteban R., Viladomiu L., López-Talavera J. C., González A., Hernández J. M., Roget M., Vargas V., Genescà J., Buti M. Hepatitis C virus antibodies among risk groups in Spain. Lancet. 1989 Aug 5;2(8658):294–297. doi: 10.1016/s0140-6736(89)90485-6. [DOI] [PubMed] [Google Scholar]
  45. Estruch R., Fernández-Solá J., Sacanella E., Paré C., Rubin E., Urbano-Márquez A. Relationship between cardiomyopathy and liver disease in chronic alcoholism. Hepatology. 1995 Aug;22(2):532–538. [PubMed] [Google Scholar]
  46. Evans R. W. Organ transplantation and the inevitable debate as to what constitutes a basic health care benefit. Clin Transpl. 1993:359–391. [PubMed] [Google Scholar]
  47. Farges O., Malassagne B., Sebagh M., Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery. 1995 Feb;117(2):146–155. doi: 10.1016/s0039-6060(05)80078-9. [DOI] [PubMed] [Google Scholar]
  48. Farrant J. M., Hayllar K. M., Wilkinson M. L., Karani J., Portmann B. C., Westaby D., Williams R. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 1991 Jun;100(6):1710–1717. doi: 10.1016/0016-5085(91)90673-9. [DOI] [PubMed] [Google Scholar]
  49. Fattovich G., Brollo L., Giustina G., Noventa F., Pontisso P., Alberti A., Realdi G., Ruol A. Natural history and prognostic factors for chronic hepatitis type B. Gut. 1991 Mar;32(3):294–298. doi: 10.1136/gut.32.3.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Fattovich G., Giustina G., Degos F., Tremolada F., Diodati G., Almasio P., Nevens F., Solinas A., Mura D., Brouwer J. T. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997 Feb;112(2):463–472. doi: 10.1053/gast.1997.v112.pm9024300. [DOI] [PubMed] [Google Scholar]
  51. Figueras J., Jaurrieta E., Valls C., Benasco C., Rafecas A., Xiol X., Fabregat J., Casanovas T., Torras J., Baliellas C. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology. 1997 Jun;25(6):1485–1489. doi: 10.1002/hep.510250629. [DOI] [PubMed] [Google Scholar]
  52. First M. R. Transplantation in the nineties. Transplantation. 1992 Jan;53(1):1–11. doi: 10.1097/00007890-199201000-00001. [DOI] [PubMed] [Google Scholar]
  53. Flickinger J. C., Epstein A. H., Iwatsuki S., Carr B. I., Starzl T. E. Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases. Cancer. 1991 Jul 15;68(2):289–294. doi: 10.1002/1097-0142(19910715)68:2<289::aid-cncr2820680213>3.0.co;2-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Forbes A., Williams R. Increasing age--an important adverse prognostic factor in hepatitis A virus infection. J R Coll Physicians Lond. 1988 Oct;22(4):237–239. [PMC free article] [PubMed] [Google Scholar]
  55. Foster P. F., Fabrega F., Karademir S., Sankary H. N., Mital D., Williams J. W. Prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Hepatology. 1997 Jun;25(6):1469–1477. doi: 10.1002/hep.510250627. [DOI] [PubMed] [Google Scholar]
  56. Franco D., Capussotti L., Smadja C., Bouzari H., Meakins J., Kemeny F., Grange D., Dellepiane M. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology. 1990 Mar;98(3):733–738. [PubMed] [Google Scholar]
  57. Friis H., Andreasen P. B. Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med. 1992 Aug;232(2):133–138. doi: 10.1111/j.1365-2796.1992.tb00562.x. [DOI] [PubMed] [Google Scholar]
  58. Gane E. J., Portmann B. C., Naoumov N. V., Smith H. M., Underhill J. A., Donaldson P. T., Maertens G., Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996 Mar 28;334(13):815–820. doi: 10.1056/NEJM199603283341302. [DOI] [PubMed] [Google Scholar]
  59. García Rodríguez L. A., Pérez Gutthann S., Walker A. M., Lueck L. The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ. 1992 Oct 10;305(6858):865–868. doi: 10.1136/bmj.305.6858.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Gimson A. E., O'Grady J., Ede R. J., Portmann B., Williams R. Late onset hepatic failure: clinical, serological and histological features. Hepatology. 1986 Mar-Apr;6(2):288–294. doi: 10.1002/hep.1840060222. [DOI] [PubMed] [Google Scholar]
  61. Ginés P., Quintero E., Arroyo V., Terés J., Bruguera M., Rimola A., Caballería J., Rodés J., Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987 Jan-Feb;7(1):122–128. doi: 10.1002/hep.1840070124. [DOI] [PubMed] [Google Scholar]
  62. Gluud C., Henriksen J. H., Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology. 1988 Mar-Apr;8(2):222–227. doi: 10.1002/hep.1840080205. [DOI] [PubMed] [Google Scholar]
  63. Gordon F. H., Mistry P. K., Sabin C. A., Lee C. A. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut. 1998 May;42(5):744–749. doi: 10.1136/gut.42.5.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Gores G. J. Liver transplantation for malignant disease. Gastroenterol Clin North Am. 1993 Jun;22(2):285–299. [PubMed] [Google Scholar]
  65. Goss J. A., Shackleton C. R., Farmer D. G., Arnaout W. S., Seu P., Markowitz J. S., Martin P., Stribling R. J., Goldstein L. I., Busuttil R. W. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg. 1997 May;225(5):472–483. doi: 10.1097/00000658-199705000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Gough A., Chapman S., Wagstaff K., Emery P., Elias E. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ. 1996 Jan 20;312(7024):169–172. doi: 10.1136/bmj.312.7024.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Gozzetti G., Mazziotti A., Grazi G. L., Jovine E., Gallucci A., Morganti M., Frena A., Aguero V., Cavallari A. Surgical experience with 168 primary liver cell carcinomas treated with hepatic resection. J Surg Oncol Suppl. 1993;3:59–61. doi: 10.1002/jso.2930530517. [DOI] [PubMed] [Google Scholar]
  68. Grant B. F., Dufour M. C., Harford T. C. Epidemiology of alcoholic liver disease. Semin Liver Dis. 1988 Feb;8(1):12–25. doi: 10.1055/s-2008-1040525. [DOI] [PubMed] [Google Scholar]
  69. Grellier L., Mutimer D., Ahmed M., Brown D., Burroughs A. K., Rolles K., McMaster P., Beranek P., Kennedy F., Kibbler H. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet. 1996 Nov 2;348(9036):1212–1215. doi: 10.1016/s0140-6736(96)04444-3. [DOI] [PubMed] [Google Scholar]
  70. Griffith J. F., Mahmoud A. E., Cooper S., Elias E., West R. J., Olliff S. P. Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. Clin Radiol. 1996 Nov;51(11):775–784. doi: 10.1016/s0009-9260(96)80005-5. [DOI] [PubMed] [Google Scholar]
  71. Gunnell D., Hawton K., Murray V., Garnier R., Bismuth C., Fagg J., Simkin S. Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified? J Epidemiol Community Health. 1997 Apr;51(2):175–179. doi: 10.1136/jech.51.2.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Harper C. G., Kril J. J. Neuropathology of alcoholism. Alcohol Alcohol. 1990;25(2-3):207–216. doi: 10.1093/oxfordjournals.alcalc.a044994. [DOI] [PubMed] [Google Scholar]
  73. Harrison J., McKiernan J., Neuberger J. M. A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl Int. 1997;10(5):369–374. doi: 10.1007/s001470050072. [DOI] [PubMed] [Google Scholar]
  74. Harrison P. M., O'Grady J. G., Keays R. T., Alexander G. J., Williams R. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ. 1990 Oct 27;301(6758):964–966. doi: 10.1136/bmj.301.6758.964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Harrison R. F., Davies M. H., Neuberger J. M., Hubscher S. G. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology. 1994 Aug;20(2):356–361. [PubMed] [Google Scholar]
  76. Haydon G. H., Jarvis L. M., Simmonds P., Harrison D. J., Garden O. J., Hayes P. C. Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population. Gut. 1997 Jan;40(1):128–132. doi: 10.1136/gut.40.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Hegarty J. E., Nouri Aria K. T., Portmann B., Eddleston A. L., Williams R. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology. 1983 Sep-Oct;3(5):685–689. doi: 10.1002/hep.1840030510. [DOI] [PubMed] [Google Scholar]
  78. Hemming A. W., Langer B., Greig P., Taylor B. R., Adams R., Heathcote E. J. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg. 1996 Jan;171(1):176–181. doi: 10.1016/S0002-9610(99)80095-6. [DOI] [PubMed] [Google Scholar]
  79. Henderson J. M., Warren W. D., Millikan W. J., Jr, Galloway J. R., Kawasaki S., Stahl R. L., Hertzler G. Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome. Am J Surg. 1990 Jan;159(1):41–50. doi: 10.1016/s0002-9610(05)80605-1. [DOI] [PubMed] [Google Scholar]
  80. Hodges J. R., Millward-Sadler G. H., Wright R. Chronic active hepatitis: the spectrum of disease. Lancet. 1982 Mar 6;1(8271):550–552. doi: 10.1016/s0140-6736(82)92056-6. [DOI] [PubMed] [Google Scholar]
  81. Holmgren G., Ericzon B. G., Groth C. G., Steen L., Suhr O., Andersen O., Wallin B. G., Seymour A., Richardson S., Hawkins P. N. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 1993 May 1;341(8853):1113–1116. doi: 10.1016/0140-6736(93)93127-m. [DOI] [PubMed] [Google Scholar]
  82. Ishak K. G., Sesterhenn I. A., Goodman Z. D., Rabin L., Stromeyer F. W. Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol. 1984 Sep;15(9):839–852. doi: 10.1016/s0046-8177(84)80145-8. [DOI] [PubMed] [Google Scholar]
  83. Ismail T., Angrisani L., Gunson B. K., Hübscher S. G., Buckels J. A., Neuberger J. M., Elias E., McMaster P. Primary hepatic malignancy: the role of liver transplantation. Br J Surg. 1990 Sep;77(9):983–987. doi: 10.1002/bjs.1800770908. [DOI] [PubMed] [Google Scholar]
  84. Iwatsuki S., Gordon R. D., Shaw B. W., Jr, Starzl T. E. Role of liver transplantation in cancer therapy. Ann Surg. 1985 Oct;202(4):401–407. doi: 10.1097/00000658-198510000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Iwatsuki S., Starzl T. E., Sheahan D. G., Yokoyama I., Demetris A. J., Todo S., Tzakis A. G., Van Thiel D. H., Carr B., Selby R. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991 Sep;214(3):221–229. doi: 10.1097/00000658-199109000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Johnson P. J., McFarlane I. G. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993 Oct;18(4):998–1005. doi: 10.1002/hep.1840180435. [DOI] [PubMed] [Google Scholar]
  87. Johnson P. J. Treatment of autoimmune hepatitis. Gut. 1997 Jul;41(1):3–4. doi: 10.1136/gut.41.1.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Karvountzis G. G., Redeker A. G. Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Ann Intern Med. 1974 Feb;80(2):156–160. doi: 10.7326/0003-4819-80-2-156. [DOI] [PubMed] [Google Scholar]
  89. Keating J. J., Johnson R. D., Johnson P. J., Williams R. Clinical course of cirrhosis in young adults and therapeutic potential of liver transplantation. Gut. 1985 Dec;26(12):1359–1363. doi: 10.1136/gut.26.12.1359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Keating J. J., O'Brien C. J., Stellon A. J., Portmann B. C., Johnson R. D., Johnson P. J., Williams R. Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients. Q J Med. 1987 Jan;62(237):59–66. [PubMed] [Google Scholar]
  91. Klein A. S., Cameron J. L. Diagnosis and management of the Budd-Chiari syndrome. Am J Surg. 1990 Jul;160(1):128–133. doi: 10.1016/s0002-9610(05)80882-7. [DOI] [PubMed] [Google Scholar]
  92. Klempnauer J., Ridder G. J., Werner M., Weimann A., Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer. 1997 Jan 1;79(1):26–34. [PubMed] [Google Scholar]
  93. Knechtle S. J., D'Alessandro A. M., Harms B. A., Pirsch J. D., Belzer F. O., Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery. 1995 Oct;118(4):615–620. doi: 10.1016/s0039-6060(05)80026-1. [DOI] [PubMed] [Google Scholar]
  94. Lang H., Oldhafer K. J., Weimann A., Schlitt H. J., Scheumann G. F., Flemming P., Ringe B., Pichlmayr R. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg. 1997 Apr;225(4):347–354. doi: 10.1097/00000658-199704000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Le Treut Y. P., Delpero J. R., Dousset B., Cherqui D., Segol P., Mantion G., Hannoun L., Benhamou G., Launois B., Boillot O. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg. 1997 Apr;225(4):355–364. doi: 10.1097/00000658-199704000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Leevy C. M. Cirrhosis in alcoholics. Med Clin North Am. 1968 Nov;52(6):1445–1455. [PubMed] [Google Scholar]
  97. Lerut J. P., Laterre P. F., Lavenne-Pardonge E., Donataccio M., Geubel A., Reynaert M. S., Otte J. B. Liver transplantation and haemophilia A. J Hepatol. 1995 May;22(5):583–585. doi: 10.1016/0168-8278(95)80454-4. [DOI] [PubMed] [Google Scholar]
  98. Livraghi T., Lazzaroni S., Meloni F., Torzilli G., Vettori C. Intralesional ethanol in the treatment of unresectable liver cancer. World J Surg. 1995 Nov-Dec;19(6):801–806. doi: 10.1007/BF00299774. [DOI] [PubMed] [Google Scholar]
  99. Lowe D., O'Grady J. G., McEwen J., Williams R. Quality of life following liver transplantation: a preliminary report. J R Coll Physicians Lond. 1990 Jan;24(1):43–46. [PMC free article] [PubMed] [Google Scholar]
  100. Lucey M. R., Carr K., Beresford T. P., Fisher L. R., Shieck V., Brown K. A., Campbell D. A., Appelman H. D. Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study. Hepatology. 1997 May;25(5):1223–1227. doi: 10.1002/hep.510250526. [DOI] [PubMed] [Google Scholar]
  101. Maddrey W. C. Alcoholic hepatitis: clinicopathologic features and therapy. Semin Liver Dis. 1988 Feb;8(1):91–102. doi: 10.1055/s-2008-1040531. [DOI] [PubMed] [Google Scholar]
  102. Maddrey W. C., Boitnott J. K., Bedine M. S., Weber F. L., Jr, Mezey E., White R. I., Jr Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978 Aug;75(2):193–199. [PubMed] [Google Scholar]
  103. Majid A., Holmes R., Desselberger U., Simmonds P., McKee T. A. Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. J Med Virol. 1995 May;46(1):48–51. doi: 10.1002/jmv.1890460111. [DOI] [PubMed] [Google Scholar]
  104. Makin A. J., Wendon J., Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology. 1995 Dec;109(6):1907–1916. doi: 10.1016/0016-5085(95)90758-0. [DOI] [PubMed] [Google Scholar]
  105. Marino I. R., Todo S., Tzakis A. G., Klintmalm G., Kelleher M., Iwatsuki S., Starzl T. E., Esquivel C. O. Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer. 1988 Nov 15;62(10):2079–2084. doi: 10.1002/1097-0142(19881115)62:10<2079::aid-cncr2820621002>3.0.co;2-j. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Markus B. H., Dickson E. R., Grambsch P. M., Fleming T. R., Mazzaferro V., Klintmalm G. B., Wiesner R. H., Van Thiel D. H., Starzl T. E. Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med. 1989 Jun 29;320(26):1709–1713. doi: 10.1056/NEJM198906293202602. [DOI] [PubMed] [Google Scholar]
  107. Mass K., Quint E. H., Punch M. R., Merion R. M. Gynecological and reproductive function after liver transplantation. Transplantation. 1996 Aug 27;62(4):476–479. doi: 10.1097/00007890-199608270-00009. [DOI] [PubMed] [Google Scholar]
  108. Maxwell J. D., Knapman P. Effect of coroners' rules on death certification for alcoholic liver disease. Br Med J (Clin Res Ed) 1985 Sep 14;291(6497):708–708. doi: 10.1136/bmj.291.6497.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. McCarthy P. M., van Heerden J. A., Adson M. A., Schafer L. W., Wiesner R. H. The Budd-Chiari syndrome. Medical and surgical management of 30 patients. Arch Surg. 1985 Jun;120(6):657–662. doi: 10.1001/archsurg.1985.01390300007001. [DOI] [PubMed] [Google Scholar]
  110. McCullough A. J., Tavill A. S. Disordered energy and protein metabolism in liver disease. Semin Liver Dis. 1991 Nov;11(4):265–277. doi: 10.1055/s-2008-1040445. [DOI] [PubMed] [Google Scholar]
  111. McLindon J. P., Paver W. K., Babbs C., Yates A. D., McMahon R. F., Love E. M., Craske J., Christopher J., Warnes T. W. Hepatitis C-related chronic liver disease among asymptomatic blood donors in the north west of England. J Infect. 1995 May;30(3):253–259. doi: 10.1016/s0163-4453(95)90854-4. [DOI] [PubMed] [Google Scholar]
  112. McPeake J. R., O'Grady J. G., Zaman S., Portmann B., Wight D. G., Tan K. C., Calne R. Y., Williams R. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol. 1993 Jun;18(2):226–234. doi: 10.1016/s0168-8278(05)80250-8. [DOI] [PubMed] [Google Scholar]
  113. Mendenhall C. L. Alcoholic hepatitis. Clin Gastroenterol. 1981 May;10(2):417–441. [PubMed] [Google Scholar]
  114. Mendenhall C. L., Anderson S., Garcia-Pont P., Goldberg S., Kiernan T., Seeff L. B., Sorrell M., Tamburro C., Weesner R., Zetterman R. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med. 1984 Dec 6;311(23):1464–1470. doi: 10.1056/NEJM198412063112302. [DOI] [PubMed] [Google Scholar]
  115. Metcalf J. V., Bhopal R. S., Gray J., Howel D., James O. F. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol. 1997 Aug;26(4):830–836. doi: 10.1093/ije/26.4.830. [DOI] [PubMed] [Google Scholar]
  116. Metcalf J., James O. The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis. 1997 Feb;17(1):13–22. doi: 10.1055/s-2007-1007179. [DOI] [PubMed] [Google Scholar]
  117. Mitchell I., Wendon J., Fitt S., Williams R. Anti-tuberculous therapy and acute liver failure. Lancet. 1995 Mar 4;345(8949):555–556. doi: 10.1016/s0140-6736(95)90468-9. [DOI] [PubMed] [Google Scholar]
  118. Mutimer D. J., Ayres R. C., Neuberger J. M., Davies M. H., Holguin J., Buckels J. A., Mayer A. D., McMaster P., Elias E. Serious paracetamol poisoning and the results of liver transplantation. Gut. 1994 Jun;35(6):809–814. doi: 10.1136/gut.35.6.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Mutimer D. J., Harrison R. F., O'Donnell K. B., Shaw J., Martin B. A., Atrah H., Ala F. A., Skidmore S., Hubscher S. G., Neuberger J. M. Hepatitis C virus infection in the asymptomatic British blood donor. J Viral Hepat. 1995;2(1):47–53. doi: 10.1111/j.1365-2893.1995.tb00071.x. [DOI] [PubMed] [Google Scholar]
  120. Nashan B., Schlitt H. J., Tusch G., Oldhafer K. J., Ringe B., Wagner S., Pichlmayr R. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology. 1996 May;23(5):1105–1111. doi: 10.1002/hep.510230526. [DOI] [PubMed] [Google Scholar]
  121. Naumann U., Protzer-Knolle U., Berg T., Leder K., Lobeck H., Bechstein W. O., Gerken G., Hopf U., Neuhaus P. A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis. Hepatology. 1997 Aug;26(2):478–484. doi: 10.1002/hep.510260232. [DOI] [PubMed] [Google Scholar]
  122. Neuberger J. M., Gunson B. K., Buckels J. A., Elias E., McMaster P. Referral of patients with primary biliary cirrhosis for liver transplantation. Gut. 1990 Sep;31(9):1069–1072. doi: 10.1136/gut.31.9.1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Neuberger J. M., Gunson B. K., Buckels J. A., Elias E., McMaster P. Referral of patients with primary biliary cirrhosis for liver transplantation. Gut. 1990 Sep;31(9):1069–1072. doi: 10.1136/gut.31.9.1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Nishiguchi S., Kuroki T., Yabusako T., Seki S., Kobayashi K., Monna T., Otani S., Sakurai M., Shikata T., Yamamoto S. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology. 1991 Dec;14(6):985–989. [PubMed] [Google Scholar]
  125. Nonami T., Yokoyama I., Iwatsuki S., Starzl T. E. The incidence of portal vein thrombosis at liver transplantation. Hepatology. 1992 Nov;16(5):1195–1198. [PMC free article] [PubMed] [Google Scholar]
  126. Nordback I. H., Pitt H. A., Coleman J., Venbrux A. C., Dooley W. C., Yeu N. N., Cameron J. L. Unresectable hilar cholangiocarcinoma: percutaneous versus operative palliation. Surgery. 1994 May;115(5):597–603. [PubMed] [Google Scholar]
  127. O'Grady J. G., Alexander G. J., Hayllar K. M., Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989 Aug;97(2):439–445. doi: 10.1016/0016-5085(89)90081-4. [DOI] [PubMed] [Google Scholar]
  128. O'Grady J. G., Polson R. J., Rolles K., Calne R. Y., Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg. 1988 Apr;207(4):373–379. doi: 10.1097/00000658-198804000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. O'Grady J. G., Schalm S. W., Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993 Jul 31;342(8866):273–275. doi: 10.1016/0140-6736(93)91818-7. [DOI] [PubMed] [Google Scholar]
  130. O'Grady J. G., Smith H. M., Davies S. E., Daniels H. M., Donaldson P. T., Tan K. C., Portmann B., Alexander G. J., Williams R. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol. 1992 Jan;14(1):104–111. doi: 10.1016/0168-8278(92)90138-f. [DOI] [PubMed] [Google Scholar]
  131. O'Grady J. G., Wendon J., Tan K. C., Potter D., Cottam S., Cohen A. T., Gimson A. E., Williams R. Liver transplantation after paracetamol overdose. BMJ. 1991 Jul 27;303(6796):221–223. doi: 10.1136/bmj.303.6796.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Ochs A., Sellinger M., Haag K., Nöldge G., Herbst E. W., Walter E., Gerok W., Rössle M. Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol. 1993 Jun;18(2):217–225. doi: 10.1016/s0168-8278(05)80249-1. [DOI] [PubMed] [Google Scholar]
  133. Ohno T., Lau J. Y. The "gold-standard," accuracy, and the current concepts: hepatitis C virus genotype and viremia. Hepatology. 1996 Nov;24(5):1312–1315. doi: 10.1002/hep.510240552. [DOI] [PubMed] [Google Scholar]
  134. Okolicsanyi L., Fabris L., Viaggi S., Carulli N., Podda M., Ricci G. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol. 1996 Jul;8(7):685–691. [PubMed] [Google Scholar]
  135. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 1992 May;15(5):948–963. doi: 10.1002/hep.1840150532. [DOI] [PubMed] [Google Scholar]
  136. Orrego H., Israel Y., Blake J. E., Medline A. Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity. Hepatology. 1983 Nov-Dec;3(6):896–905. doi: 10.1002/hep.1840030602. [DOI] [PubMed] [Google Scholar]
  137. Parés A., Barrera J. M., Caballería J., Ercilla G., Bruguera M., Caballería L., Castillo R., Rodés J. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology. 1990 Dec;12(6):1295–1299. doi: 10.1002/hep.1840120608. [DOI] [PubMed] [Google Scholar]
  138. Pauwels A., Mostefa-Kara N., Florent C., Lévy V. G. Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol. 1993 Jan;17(1):124–127. doi: 10.1016/s0168-8278(05)80532-x. [DOI] [PubMed] [Google Scholar]
  139. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 1991 Oct;110(4):726–735. [PubMed] [Google Scholar]
  140. Pereira S. P., Williams R. Limits to liver transplantation in the UK. Gut. 1998 Jun;42(6):883–885. doi: 10.1136/gut.42.6.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Pichlmayr R. Is there a place for liver grafting for malignancy? Transplant Proc. 1988 Feb;20(1 Suppl 1):478–482. [PubMed] [Google Scholar]
  142. Pichlymayr R., Ringe B., Wittekind C., Bunzendahl H., Gubernatis G., Grote R., Mauz S., Grosse H. Liver grafting for malignant liver tumors. Transplant Proc. 1989 Feb;21(1 Pt 2):2403–2405. [PubMed] [Google Scholar]
  143. Pomfret E. A., Lewis W. D., Jenkins R. L., Bergethon P., Dubrey S. W., Reisinger J., Falk R. H., Skinner M. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation. 1998 Apr 15;65(7):918–925. doi: 10.1097/00007890-199804150-00010. [DOI] [PubMed] [Google Scholar]
  144. Powell L. W. Does transplantation of the liver cure genetic hemochromatosis? J Hepatol. 1992 Nov;16(3):259–261. doi: 10.1016/s0168-8278(05)80654-3. [DOI] [PubMed] [Google Scholar]
  145. Poynard T., Barthelemy P., Fratte S., Boudjema K., Doffoel M., Vanlemmens C., Miguet J. P., Mantion G., Messner M., Launois B. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet. 1994 Aug 20;344(8921):502–507. doi: 10.1016/s0140-6736(94)91897-x. [DOI] [PubMed] [Google Scholar]
  146. Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997 Mar 22;349(9055):825–832. doi: 10.1016/s0140-6736(96)07642-8. [DOI] [PubMed] [Google Scholar]
  147. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
  148. Ramond M. J., Poynard T., Rueff B., Mathurin P., Théodore C., Chaput J. C., Benhamou J. P. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med. 1992 Feb 20;326(8):507–512. doi: 10.1056/NEJM199202203260802. [DOI] [PubMed] [Google Scholar]
  149. Realdi G., Fattovich G., Hadziyannis S., Schalm S. W., Almasio P., Sanchez-Tapias J., Christensen E., Giustina G., Noventa F. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol. 1994 Oct;21(4):656–666. doi: 10.1016/s0168-8278(94)80115-0. [DOI] [PubMed] [Google Scholar]
  150. Ricci P., Therneau T. M., Malinchoc M., Benson J. T., Petz J. L., Klintmalm G. B., Crippin J. S., Wiesner R. H., Steers J. L., Rakela J. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology. 1997 Mar;25(3):672–677. doi: 10.1002/hep.510250330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Ringe B., Lang H., Oldhafer K. J., Gebel M., Flemming P., Georgii A., Borst H. G., Pichlmayr R. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology. 1995 May;21(5):1337–1344. [PubMed] [Google Scholar]
  152. Ringe B., Pichlmayr R., Wittekind C., Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg. 1991 Mar-Apr;15(2):270–285. doi: 10.1007/BF01659064. [DOI] [PubMed] [Google Scholar]
  153. Rizzetto M., Verme G., Gerin J. L., Purcell R. H. Hepatitis delta virus disease. Prog Liver Dis. 1986;8:417–431. [PubMed] [Google Scholar]
  154. Roudot-Thoraval F., Bastie A., Pawlotsky J. M., Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology. 1997 Aug;26(2):485–490. doi: 10.1002/hep.510260233. [DOI] [PubMed] [Google Scholar]
  155. Routley D., Ramage J. K., McPeake J., Tan K. C., Williams R. Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver. Liver Transpl Surg. 1995 Mar;1(2):118–121. doi: 10.1002/lt.500010209. [DOI] [PubMed] [Google Scholar]
  156. Saibara T., Onishi S., Sone J., Yamamoto N., Shimahara Y., Mori K., Ozawa K., Yamamoto Y. Arterial ketone body ratio as a possible indicator for liver transplantation in fulminant hepatic failure. Transplantation. 1991 Apr;51(4):782–786. doi: 10.1097/00007890-199104000-00009. [DOI] [PubMed] [Google Scholar]
  157. Sakuma K., Saitoh N., Kasai M., Jitsukawa H., Yoshino I., Yamaguchi M., Nobutomo K., Yamumi M., Tsuda F., Komazawa T. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology. 1988 Nov-Dec;8(6):1642–1646. doi: 10.1002/hep.1840080628. [DOI] [PubMed] [Google Scholar]
  158. Samuel D., Bismuth A., Mathieu D., Arulnaden J. L., Reynes M., Benhamou J. P., Brechot C., Bismuth H. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet. 1991 Apr 6;337(8745):813–815. doi: 10.1016/0140-6736(91)92515-4. [DOI] [PubMed] [Google Scholar]
  159. Samuel D., Muller R., Alexander G., Fassati L., Ducot B., Benhamou J. P., Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med. 1993 Dec 16;329(25):1842–1847. doi: 10.1056/NEJM199312163292503. [DOI] [PubMed] [Google Scholar]
  160. Sanchez-Urdazpal L., Czaja A. J., van Hoek B., Krom R. A., Wiesner R. H. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology. 1992 Feb;15(2):215–221. doi: 10.1002/hep.1840150208. [DOI] [PubMed] [Google Scholar]
  161. Scaiola A., MacMathuna P., Langley P. G., Gove C. D., Hughes R. D., Williams R. Determination of the ketone body ratio in fulminant hepatic failure. Hepatogastroenterology. 1990 Aug;37(4):413–416. [PubMed] [Google Scholar]
  162. Schilsky M. L., Scheinberg I. H., Sternlieb I. Liver transplantation for Wilson's disease: indications and outcome. Hepatology. 1994 Mar;19(3):583–587. doi: 10.1002/hep.1840190307. [DOI] [PubMed] [Google Scholar]
  163. Seaberg E. C., Belle S. H., Beringer K. C., Schivins J. L., Detre K. M. Long-term patient and retransplantation-free survival by selected recipient and donor characteristics: an update from the Pitt-UNOS Liver Transplant Registry. Clin Transpl. 1997:15–28. [PubMed] [Google Scholar]
  164. Seu P., Shackleton C. R., Shaked A., Imagawa D. K., Olthoff K. M., Rudich S. R., Kinkhabwala M., Busuttil R. W. Improved results of liver transplantation in patients with portal vein thrombosis. Arch Surg. 1996 Aug;131(8):840–845. doi: 10.1001/archsurg.1996.01430200050009. [DOI] [PubMed] [Google Scholar]
  165. Shaked A., Goldstein R. M., Klintmalm G. B., Drazan K., Husberg B., Busuttil R. W. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet. 1992 Jun;174(6):453–459. [PubMed] [Google Scholar]
  166. Shakil A. O., Pinna A., Demetris J., Lee R. G., Fung J. J., Rakela J. Survival and quality of life after liver transplantation for acute alcoholic hepatitis. Liver Transpl Surg. 1997 May;3(3):240–244. [PubMed] [Google Scholar]
  167. Shaw B. W., Jr, Wood R. P., Stratta R. J., Pillen T. J., Langnas A. N. Stratifying the causes of death in liver transplant recipients. An approach to improving survival. Arch Surg. 1989 Aug;124(8):895–900. doi: 10.1001/archsurg.1989.01410080025003. [DOI] [PubMed] [Google Scholar]
  168. Sheng R., Campbell W. L., Zajko A. B., Baron R. L. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease. AJR Am J Roentgenol. 1996 May;166(5):1109–1113. doi: 10.2214/ajr.166.5.8615253. [DOI] [PubMed] [Google Scholar]
  169. Shetty K., Rybicki L., Carey W. D. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology. 1997 May;25(5):1049–1053. doi: 10.1002/hep.510250501. [DOI] [PubMed] [Google Scholar]
  170. Sheu J. C., Sung J. L., Chen D. S., Yang P. M., Lai M. Y., Lee C. S., Hsu H. C., Chuang C. N., Yang P. C., Wang T. H. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology. 1985 Aug;89(2):259–266. doi: 10.1016/0016-5085(85)90324-5. [DOI] [PubMed] [Google Scholar]
  171. Slapak G. I., Saxena R., Portmann B., Gane E., Devlin J., Calne R., Williams R. Graft and systemic disease in long-term survivors of liver transplantation. Hepatology. 1997 Jan;25(1):195–202. doi: 10.1002/hep.510250136. [DOI] [PubMed] [Google Scholar]
  172. Starzl T. E., Groth C. G., Brettschneider L., Penn I., Fulginiti V. A., Moon J. B., Blanchard H., Martin A. J., Jr, Porter K. A. Orthotopic homotransplantation of the human liver. Ann Surg. 1968 Sep;168(3):392–415. doi: 10.1097/00000658-196809000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Starzl T. E., Reyes J., Tzakis A., Mieles L., Todo S., Gordon R. Liver transplantation for polycystic liver disease. Arch Surg. 1990 May;125(5):575–577. doi: 10.1001/archsurg.1990.01410170021003. [DOI] [PubMed] [Google Scholar]
  174. Starzl T. E., Todo S., Gordon R., Makowa L., Tzakis A., Iwatsuki S., Marsh W., Esquivel C., Van Thiel D. Liver transplantation in older patients. N Engl J Med. 1987 Feb 19;316(8):484–485. doi: 10.1056/NEJM198702193160814. [DOI] [PubMed] [Google Scholar]
  175. Steinbrook R. Allocating livers--devising a fair system. N Engl J Med. 1997 Feb 6;336(6):436–438. doi: 10.1056/NEJM199702063360610. [DOI] [PubMed] [Google Scholar]
  176. Steinherz L., Steinherz P. Delayed cardiac toxicity from anthracycline therapy. Pediatrician. 1991;18(1):49–52. [PubMed] [Google Scholar]
  177. Stone M. J., Klintmalm G. B., Polter D., Husberg B. S., Mennel R. G., Ramsay M. A., Flemens E. R., Goldstein R. M. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology. 1993 Jan;104(1):196–202. doi: 10.1016/0016-5085(93)90852-4. [DOI] [PubMed] [Google Scholar]
  178. Stuart K. E., Anand A. J., Jenkins R. L. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer. 1996 Jun 1;77(11):2217–2222. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
  179. Suhr O. B., Wiklund U., Eleborg L., Ando Y., Backman C., Birgersdotter V., Bjerle P., Ericzon B. G., Johansson B., Olofsson B. O. Impact of autonomic neuropathy on circulatory instability during liver transplantation for familial amyloidotic polyneuropathy. Transplantation. 1997 Mar 15;63(5):675–679. doi: 10.1097/00007890-199703150-00011. [DOI] [PubMed] [Google Scholar]
  180. Tarter R. E., Erb S., Biller P. A., Switala J., Van Thiel D. H. The quality of life following liver transplantation: a preliminary report. Gastroenterol Clin North Am. 1988 Mar;17(1):207–217. [PubMed] [Google Scholar]
  181. Theodossi A., Eddleston A. L., Williams R. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut. 1982 Jan;23(1):75–79. doi: 10.1136/gut.23.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Titó L., Rimola A., Ginès P., Llach J., Arroyo V., Rodés J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology. 1988 Jan-Feb;8(1):27–31. doi: 10.1002/hep.1840080107. [DOI] [PubMed] [Google Scholar]
  183. Trey C. The fulminant hepatic failure surveillance study. Brief review of the effects of presumed etiology and age of survival. Can Med Assoc J. 1972 Feb 26;106:525–528. [PMC free article] [PubMed] [Google Scholar]
  184. Tygstrup N., Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis. 1986 May;6(2):129–137. doi: 10.1055/s-2008-1040596. [DOI] [PubMed] [Google Scholar]
  185. Vaillant G. E. The natural history of alcoholism and its relationship to liver transplantation. Liver Transpl Surg. 1997 May;3(3):304–310. doi: 10.1002/lt.500030318. [DOI] [PubMed] [Google Scholar]
  186. Van Thiel D. H. When should a decision to proceed with transplantation actually be made in cases of fulminant or subfulminant hepatic failure: at admission to hospital or when a donor organ is made available? J Hepatol. 1993 Jan;17(1):1–2. [PubMed] [Google Scholar]
  187. Washburn W. K., Lewis W. D., Jenkins R. L. Aggressive surgical resection for cholangiocarcinoma. Arch Surg. 1995 Mar;130(3):270–276. doi: 10.1001/archsurg.1995.01430030040006. [DOI] [PubMed] [Google Scholar]
  188. Weissberg J. I., Andres L. L., Smith C. I., Weick S., Nichols J. E., Garcia G., Robinson W. S., Merigan T. C., Gregory P. B. Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med. 1984 Nov;101(5):613–616. doi: 10.7326/0003-4819-101-5-613. [DOI] [PubMed] [Google Scholar]
  189. Wiesner R. H., Grambsch P. M., Dickson E. R., Ludwig J., MacCarty R. L., Hunter E. B., Fleming T. R., Fisher L. D., Beaver S. J., LaRusso N. F. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology. 1989 Oct;10(4):430–436. doi: 10.1002/hep.1840100406. [DOI] [PubMed] [Google Scholar]
  190. Wiesner R. H., Porayko M. K., Dickson E. R., Gores G. J., LaRusso N. F., Hay J. E., Wahlstrom H. E., Krom R. A. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 1992 Nov;16(5):1290–1299. [PubMed] [Google Scholar]
  191. Wiesner R. H., Porayko M. K., Dickson E. R., Gores G. J., LaRusso N. F., Hay J. E., Wahlstrom H. E., Krom R. A. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 1992 Nov;16(5):1290–1299. [PubMed] [Google Scholar]
  192. Williams R., Smith M., Shilkin K. B., Herbertson B., Joysey V., Calne R. Y. Liver transplantation in man: the frequency of rejection, biliary tract complications, and recurrence of malignancy based on an analysis of 26 cases. Gastroenterology. 1973 May;64(5):1026–1048. [PubMed] [Google Scholar]
  193. Wreghitt T. G., Gray J. J., Allain J. P., Poulain J., Garson J. A., Deaville R., Maple C., Parameshwar J., Calne R. Y., Wallwork J. Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol. 1994 Jun;20(6):768–772. doi: 10.1016/s0168-8278(05)80148-5. [DOI] [PubMed] [Google Scholar]
  194. Wysowski D. K., Fourcroy J. L. Flutamide hepatotoxicity. J Urol. 1996 Jan;155(1):209–212. [PubMed] [Google Scholar]
  195. Yeo C. J., Pitt H. A., Cameron J. L. Cholangiocarcinoma. Surg Clin North Am. 1990 Dec;70(6):1429–1447. doi: 10.1016/s0039-6109(16)45293-x. [DOI] [PubMed] [Google Scholar]
  196. Yokoyama I., Todo S., Iwatsuki S., Starzl T. E. Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology. 1990 Apr;37(2):188–193. [PMC free article] [PubMed] [Google Scholar]
  197. Zarski J. P., Seigneurin J. M. La variabilité génétique du virus de l'hépatitie B: relation éventuelle avec la pathogénicité. Gastroenterol Clin Biol. 1991;15(4):277–279. [PubMed] [Google Scholar]
  198. Zauner C. A., Apsner R. C., Kranz A., Kramer L., Madl C., Schneider B., Schneeweiss B., Ratheiser K., Stockenhuber F., Lenz K. Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoringsystems. Intensive Care Med. 1996 Jun;22(6):559–563. doi: 10.1007/BF01708096. [DOI] [PubMed] [Google Scholar]
  199. Zeuzem S., Franke A., Lee J. H., Herrmann G., Ruster B., Roth W. K. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology. 1996 Nov;24(5):1003–1009. doi: 10.1002/hep.510240505. [DOI] [PubMed] [Google Scholar]
  200. Zimmerman J. E., Wagner D. P., Seneff M. G., Becker R. B., Sun X., Knaus W. A. Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival. Hepatology. 1996 Jun;23(6):1393–1401. doi: 10.1002/hep.510230615. [DOI] [PubMed] [Google Scholar]
  201. de Franchis R., Meucci G., Vecchi M., Tatarella M., Colombo M., Del Ninno E., Rumi M. G., Donato M. F., Ronchi G. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med. 1993 Feb 1;118(3):191–194. doi: 10.7326/0003-4819-118-3-199302010-00006. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES